个人科研网厅 | | 帮助
首都医科大学宣武医院知识库
高级检索
当前位置： 首页 > 详情页

Comparison of neoadjuvant chemoradiotherapy with CAPEOX versus single-agent capecitabine in high-risk locally advanced rectal cancer: Long-term results from a multicenter randomized controlled trial (MONT-R)

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Lin, G.[1] * ; Zhou, J.[1] ; Li, G.[1] ; Xiao, Y.[1] ; Jia, W.[2] ; Liu, Q.[3] ; Wu, B.[1] ; Wu, A.[4] ; Han, J.[5] ; Wang, Z.[5] ; Yao, H.[6] ; Shen, Z.[7] ; Li, A.[8] ; Zhang, Z.[9] ;
机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing, Peoples R China [2]Chinese Acad Med Sci, Beijing Hosp, Dept Gen Surg, Beijing, Peoples R China [3]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Dept Colorectal Surg,Canc Hosp, Beijing, Peoples R China [4]Peking Univ Canc Hosp & Inst, Gastrointestinal Canc Ctr, Key Lab Carcinogenesis & Translat Res, Minist Educ,Unit 3, Beijing, Peoples R China [5]Capital Med Univ, Beijing Chaoyang Hosp, Dept Gen Surg, Beijing, Peoples R China [6]Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China [7]Peking Univ, Peoples Hosp, Dept Surg Gastroenterol, Beijing, Peoples R China [8]Capital Med Univ, Beijing Xuanwu Hosp, Dept Gen Surg, Beijing, Peoples R China [9]Hebei Med Univ, Dept Gen Surg, Hosp 4, Shijiazhuang, Hebei, Peoples R China
出处：
DOI： 10.1016/j.annonc.2023.09.1787
ISSN：
基金：
Major Grants Program of Beijing Science and Technology Commission [D171100002617003]; National High Level Hospital Clinical Research Funding [2022-PUMCH-C-005]
语种：
外文
被引次数：
WOS：
中科院(CAS)分区：
出版当年[2022]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2021]版：
Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Lin G.,Zhou J.,Li G.,et al.Comparison of neoadjuvant chemoradiotherapy with CAPEOX versus single-agent capecitabine in high-risk locally advanced rectal cancer: Long-term results from a multicenter randomized controlled trial (MONT-R)[J].ANNALS OF ONCOLOGY.2023,34:S431-S431.doi:10.1016/j.annonc.2023.09.1787.
APA：
Lin, G.,Zhou, J.,Li, G.,Xiao, Y.,Jia, W....&Zhang, Z..(2023).Comparison of neoadjuvant chemoradiotherapy with CAPEOX versus single-agent capecitabine in high-risk locally advanced rectal cancer: Long-term results from a multicenter randomized controlled trial (MONT-R).ANNALS OF ONCOLOGY,34,
MLA：
Lin, G.,et al."Comparison of neoadjuvant chemoradiotherapy with CAPEOX versus single-agent capecitabine in high-risk locally advanced rectal cancer: Long-term results from a multicenter randomized controlled trial (MONT-R)".ANNALS OF ONCOLOGY 34.(2023):S431-S431

资源点击量：16461 今日访问量：0 总访问量：871 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持：重庆聚合科技有限公司 地址：北京市西城区长椿街45号宣武医院